SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-128864
Filing Date
2008-06-05
Accepted
2008-06-05 17:00:16
Documents
6
Period of Report
2008-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17107
2 AMENDMENT LETTER dex101.htm EX-10.1 11770
3 ROYALTY AGREEMENT AMENDMENT dex102.htm EX-10.2 19198
4 REAFFIRMATION AND RATIFICATION AGREEMENT dex103.htm EX-10.3 21507
5 GUARANTY SIDE LETTER dex104.htm EX-10.4 13476
6 FORM 8-K FILED BY BIOVEST dex991.htm EX-99.1 16809
  Complete submission text file 0001193125-08-128864.txt   101494
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 000-51383 | Film No.: 08883650
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1